Autres langues UCB

Actions

UCB

BE0003739530

Produits pharmaceutiques

Temps réel Euronext Bruxelles 12:49:00 12/08/2026 Varia. 5j. Varia. 1 janv.
222,90 EUR -1,46% Graphique intraday de UCB -2,75% -6,58%

Autres langues

11/08 Berenberg Adjusts UCB Forecasts After H1 Beat; Buy Reaffirmed
11/08 Berenberg herhaalt koopadvies UCB
10/08 MoonLake's psoriatic arthritis drug meets key goals in late-stage trial
05/08 UCB Publishes Results Of Post Hoc Data Analysis Of Fintepla In Patients With Lennox-Gastaut Syndrome
03/08 Barclays verlaagt koersdoel UCB
03/08 Jefferies haalt UCB van de verkooplijst
02/08 Umicore en Syensqo blinken uit na cijfers
30/07 UCB SA Reports Earnings Results for the Half Year Ended June 30, 2026
30/07 Nieuwe outlook UCB schiet tekort
30/07 Goede eerste jaarhelft voor UCB
30/07 Goede eerste jaarhelft voor UCB
30/07 UCB shares fall despite guidance upgrade as CEO flags higher H2 costs
30/07 UCB : Delivering today, shaping what comes next
30/07 UCB verhoogt verwachting na sterk halfjaar
30/07 Biopharmaceutical Company UCB Books Higher H1 Profit, Revenue
30/07 UCB raises guidance for core earnings and revenue
30/07 UCB : Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase
29/07 Omzetgroei bij UCB verwacht
24/07 Bedrijfskalender van 27 tot 31 juli 2026
24/07 Calendario delle società: 27 - 31 luglio 2026
14/07 Where would AI lead Pharma in the long run?
13/07 Antengene Receives $60 Million Milestone in UCB Licensing Deal
12/07 Melexis onderuit in Brussel te midden van AI-malaise
09/07 UK Life Sciences Hits GBP3 Billion Investment Milestone
08/07 UCB presenteert nieuwe studiedata
Aucun résultat pour cette recherche